Clinicopathological Characteristics and Prognosis of Breast Cancer in Young Women – A Single Center Study in a Developing Country

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Cancer Stat Facts. Female breast cancer. 2018 Available from: https://seer.cancer.gov/statfacts/html/breast.html. Accessed 24, 2018.
   Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer-base no. 11, 2013 [Lyon, France: international agency for research oncancer]. Available from: http://globocan.iarc.fr/. Accessed 23, 2021.
   Google Scholar
• Villarreal-Garza C, Aguila C, Magallanes-Hoyos MC, et al. Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist. 2013;18(12):1298–1306. doi:10.1634/theoncologist.2013-032124277771
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Surveillance, epidemiology and end results program. Available from: http://seer.cancer.gov/statfacts/html/breast.html. Accessed 57, 2017.
   Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Li J, Zhang BN, Fan JH, et al. A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer. 2011;11:364. doi:10.1186/1471-2407-11-36421859480
   PubMed Web of Science ®Google Scholar
• Yao S, Xu B, Ma F, et al. Breast cancer in women younger than 25: clinicopathological features and prognostic factors. Ann Oncol. 2009;20(2):387–389. doi:10.1093/annonc/mdn71119211501
   PubMed Web of Science ®Google Scholar
• Chen H-L, Zhou M-Q, Tian W, et al. Effect of age on breast cancer patient prognoses: a population-based study using the SEER 18 database. PLoS One. 2016;11(10):e0165409. doi:10.1371/journal.pone.016540927798652
   PubMed Web of Science ®Google Scholar
• Azim HA Jr, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res. 2014;16(4):427. doi:10.1186/s13058-014-0427-525436920
   PubMed Web of Science ®Google Scholar
• Lambertini M, Pinto AC, Ameye L, et al. The prognostic performance of adjuvant! Online and Nottingham prognostic index in young breast cancer patients. Br J Cancer. 2016;115(12):1471–1478. doi:10.1038/bjc.2016.35927802449
   PubMed Web of Science ®Google Scholar
• Anders CK, Fan C, Parker JS, et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol. 2011;29(1):e18–e20. doi:10.1200/JCO.2010.28.919921115855
   PubMed Web of Science ®Google Scholar
• DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62. doi:10.3322/caac.2120324114568
   PubMed Web of Science ®Google Scholar
• Fu J, Wu L, Fu W, et al. How young is too young in breast cancer?-Young breast cancer is not a unique biological subtype. Clin Breast Cancer. 2018;18(1):e25–e39. doi:10.1016/j.clbc.2017.05.01528802528
   PubMed Web of Science ®Google Scholar
• Keegan TH, DeRouen MC, Press DJ, et al. Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res. 2012;14(2):R55. doi:10.1186/bcr315622452927
   PubMed Web of Science ®Google Scholar
• O’Brien KM, Sun J, Sandler DP, DeRoo LA, Weinberg CR. Risk factors for young-onset invasive and in situ breast cancer. Cancer Causes Control. 2015;26(12):1771–1778. doi:10.1007/s10552-015-0670-926407954
   PubMed Web of Science ®Google Scholar
• Freedman RA, Partridge AH. Management of breast cancer in very young women. Breast. 2013;22(Suppl 2):S176–S179. doi:10.1016/j.breast.2013.07.03424074783
   PubMed Web of Science ®Google Scholar
• Rosenberg SM, Partridge AH. Management of breast cancer in very young women. Breast. 2015;24(Suppl 2):S154–S158. doi:10.1016/j.breast.2015.07.03626255745
   PubMed Web of Science ®Google Scholar
• Abdel-Razeq H, Almasri H, Abdel Rahman F, et al. Clinicopathological characteristics and treatment outcomes of breast cancer among adolescents and young adults in a developing country. Cancer Manag Res. 2019;11:9891–9897. doi:10.2147/CMAR.S22933731819626
   PubMed Web of Science ®Google Scholar
• Li L, Yi Z, Li C, et al. Integrative clinical genomics of early-onset breast cancer. J Clin Oncol. 2018;36(15_suppl):1541. doi:10.1200/JCO.2018.36.15_suppl.154131329701
   PubMed Web of Science ®Google Scholar
• Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92(13):1081–1087. doi:10.1093/jnci/92.13.108110880551
   PubMedGoogle Scholar
• Foxcroft LM, Evans EB, Porter AJ. The diagnosis of breast cancer in women younger than 40. Breast. 2004;13(4):297–306. doi:10.1016/j.breast.2004.02.01215325664
   PubMed Web of Science ®Google Scholar
• Evans A, Trimboli RM, Athanasiou A, et al. Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging. 2018;9(4):449–461. doi:10.1007/s13244-018-0636-z30094592
   PubMed Web of Science ®Google Scholar
• He XM, Zou DH. The association of young age with local recurrence in women with early-stage breast cancer after breast-conserving therapy: a meta-analysis. Sci Rep. 2017;7(1):11058. doi:10.1038/s41598-017-10729-928894168
   PubMed Web of Science ®Google Scholar
• Matthews RH, McNeese MD, Montague ED, et al. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Radiat Oncol Biol Phys. 1988;14(4):659–663. doi:10.1016/0360-3016(88)90086-73350720
   PubMed Web of Science ®Google Scholar
• Kumar RV, Panwar D, Amirtham U, et al. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: a retrospective study of 5436 women from a regional cancer center in South India. South Asian J Cancer. 2018;7(1):7–10. doi:10.4103/sajc.sajc_211_1729600224
   PubMed Web of Science ®Google Scholar
• Patnayak R, Jena A, Rukmangadha N, et al. Hormone receptor status (estrogen receptor, progesterone receptor), human epidermal growth factor-2 and p53 in South Indian breast cancer patients: a tertiary care center experience. Indian J Med Paediatr Oncol. 2015;36(2):117–122. doi:10.4103/0971-5851.15884426157289
   PubMedGoogle Scholar
• Manjunath S, Prabhu JS, Kaluve R, et al. Estrogen receptor negative breast cancer in India: do we really have higher burden of this subtype? Indian J Surg Oncol. 2011;2(2):122–125. doi:10.1007/s13193-011-0072-822693404
   PubMedGoogle Scholar
• Ghosh J, Gupta S, Desai S, et al. Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. Indian J Cancer. 2011;48(4):391–396. doi:10.4103/0019-509X.9224522293249
   PubMed Web of Science ®Google Scholar
• Copson E, Eccles B, Maishman T, et al. Prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: the POSH study. J Natl Cancer Inst. 2013;105(13):978–988. doi:10.1093/jnci/djt13423723422
   PubMedGoogle Scholar
• Voduc KD, Cheang MCU, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28(10):1684–1691. doi:10.1200/JCO.2009.24.928420194857
   PubMed Web of Science ®Google Scholar
• Passhak M, Shachar SS, Bar-Sela G, et al. Breast cancer in young women aged 35 and under: patterns of care and outcome. Breast J. 2018;24(3):441–443. doi:10.1111/tbj.1296629139588
   PubMed Web of Science ®Google Scholar
• Greally M, Kielty J, Watson GA, et al. Where youth matters – clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer. Ir J Med Sci. 2019;188(1):59–67. doi:10.1007/s11845-018-1832-z29766409
   PubMed Web of Science ®Google Scholar
• de Azambuja E, Holmes AP, Piccart-Gebhart M, et al. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, Phase 3 trial and their association with pathological complete response. Lancet Oncol. 2014;15(10):1137–1146. doi:10.1016/S1470-2045(14)70320-125130998
   PubMed Web of Science ®Google Scholar
• Fredholm H, Magnusson K, Lindström LS, et al. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat. 2016;160(1):131–143. doi:10.1007/s10549-016-3983-927624330
   PubMed Web of Science ®Google Scholar
• Hwang KT, Kim J, Jung J, et al. Impact of breast cancer subtypes on prognosis of women with operable invasive breast cancer: a population-based study using SEER database. Clin Cancer Res. 2019;25(6):1970–1979. doi:10.1158/1078-0432.CCR-18-278230559169
   PubMed Web of Science ®Google Scholar